Pairing Clinical Studies with Dopaminergic Therapeutic Intervention | PMD Continuing Education

Originally presented in October 2021.

This presentation provides an in-depth exploration of dopaminergic therapies for Parkinson disease (PD), with a focus on the evidence supporting their effectiveness. Participants will gain insights into the evolving landscape of PD management, enabling them to make informed decisions about treatment options for their patients. This lecture combines historical context with current clinical evidence to provide a comprehensive overview of dopaminergic therapies in Parkinson disease.

Presented by: Fernando L. Pagán, MD

Keep learning anywhere, anytime with PMD Alliance Continuing Education. Explore our full library of free and low-cost education for healthcare providers in movement disorders here: https://education.pmdalliance.org/

** CONNECT WITH US **
Website: https://www.pmdalliance.org/
Facebook:   / pmd.alliance  
Instagram:   / pmdalliance  
LinkedIn:   / parkinson-&-movement-disorder-alliance  
Get virtual event invites: https://pmdalliance.activehosted.com/f/4
Join an online support group: https://www.pmdalliance.org/resilienc...

** ARE YOU A CARE PARTNER? Join the conversation on Care Partners Connect **
Facebook:   / parkinsonscarepartners  
Instagram:   / parkinsonscarepartners  

Parkinson & Movement Disorder Alliance (“PMD Alliance” for short) is an independent, national nonprofit dedicated to providing opportunities for people impacted by movement disorders to learn, live fully, and spark meaningful connections around them. Welcome to the PMD+ community—we take care of each other here.